The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yarema Kristin since 2021.
This trader's CIK number is 1803794.
At the time of last reporting, Yarema Kristin was the Chief Commercial Officer of Atara Biotherapeutics, Inc.. (stock ticker symbol ATRA).
Also see all insider trading activities at Atara Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ATRA | 34,354 | $499,102 | 761 | $11,072 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-11 | ATRA | Buy | 2,021 | 14.50 | 29,304 |
| 2021-06-14 | ATRA | Buy | 32,333 | 14.53 | 469,798 |
| 2021-05-18 | ATRA | Sale | 761 | 14.55 | 11,072 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yarema Kristin (Chief Commercial Officer of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.